CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologie, and genetic characteristics and differences with Hodgkin's disease

Blood

Volumn 87, Issue 7, 1996, Pages 2905-2917

  Filippa, Daniel A ^a   Ladanyi, Marc ^a   Wollner, Norma ^a   Straus, David J ^a   O'Brien, James P ^a   Portlock, Carol ^a   Gangi, Maryann ^a   Sun, Ming ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD30 ANTIGEN; LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CHROMOSOME TRANSLOCATION 2; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0029964498     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2905.bloodjournal8772905     Document Type: Article

References (53)

1. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65, 1982
2. Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V: Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small cell population. Int J Cancer 30:445, 1982
3. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
4. Froese P, Lemke H, Gerdes J, Havsteen B, Schwarting R, Hansen H, Stein H: Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. J Immunol 139:2081, 1987
5. Nawrocki JF, Kirtsen ES, Fisher RI: Biochemical and structural properties of a Hodgkin's disease-related membrane protein. J Immunol 141:672, 1988
6. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family which is characteristic for Hodgkin's disease. Cell 68:1, 1992
7. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
8. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
9. Fonatsch C, Latza U, Durkop H, Rieder H, Stein H: Assignment of the human CD30 (Ki-1) gene to 1p36. Genomics 14:825, 1992
10. Kristofferson U, Heim S, Heldrup J, Akerman M, Garwicz S, Mitelman F: Cytogenetic studies of childhood non-Hodgkin lymphomas. Hereditas 103:77, 1985
11. Fischer P, Nacheva E, Mason DY, Sherrington PD, Holye C, Hayhoe FGJ, Karpas A: A Ki-1 (CD30) positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2:5 translocation and rearrangement of the T-cell receptor B-chain gene. Blood 72:234, 1988
12. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation, t(2;5)-(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
13. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q25): A recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
14. Rimokh R, Magaud J-P, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Hematol 71:31, 1989
15. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristofferson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30 positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation in-volving 5q35. Br J Haematol 74:161, 1990
16. Ebrahim SAD, Ladanyi M, Desai SB, Offit K, Jhanwar SC, Filippa DA, Lieberman PH, Chaganti RSK: Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T cell lymphomas of uncertain lineage including 12 Ki1 positive lymphomas. Genes Chromosomes Cancer 2:27, 1990
17. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
18. Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H: Ber-H2: A new high activity monoclonal antibody to a formol resistant epitope of the Ki-1 (CD30) antigen. Immunohistochemical and immunobiochemical characterization. Blood 74:1678, 1989
19. Agnarsson BA, Kadin ME: Ki-1 positive large cell lymphoma, a morphologic and immunologie study of 19 cases. Am J Surg Pathol 12:264, 1988
20. Chan JKC, Hui PK, Leungs TW, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma: Delineation of two morphological types. Histopathology 15:11, 1989
21. Falini B, Pileri S, Stein H, Dieneman D, Dallenbach F, Delsol G, Minelli O, Poggi S, Martelli MF, Pallesen G, Palestro G: Variable expression of leukocyte common antigen (CD45) in CD30 (Ki-1)-positive anaplastic large cell (ALC) lymphoma. Implication for the differential diagnosis between lymphoid and non-lymphoid malignancies. Human Pathol 21:624. 1990
22. Greer JP, Kinney MC, Collins RD, Salhani KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 539, 1991
23. Chott A, Kaserer K, Augustin I, Vesely M, Heinz R, Oehlinger W, Hanak H, Radaszkiewicz T: Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439, 1990
24. Nakamura S, Takagi N, Kojima M, Motoori T, Kitoh K, Osada H, Suzuki H, Ogura M, Kurita S, Oyama A, Ueda R, Takahashi T, Suchi T: Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 68:118, 1991
25. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosome abnormal-ity, t(2;5)(p23:q35). Am J Surg Pathol 14:305, 1990
26. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
27. + large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895, 1994
28. Shulman L, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
29. Leoncini L, Del Vecchio MT, Kraft R, Megha T, Barbini P, Cevenini G, Poggi S, Pileri S, Tosi P, Cottier H: Hodgkin's disease and CD30-positive anaplastic large cell lymphomas: A continuous spectrum of malignant disorders. Am J Clin Pathol 137:1047, 1990
30. Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063, 1966
31. Erlandon RA: Ancillary procedures for evaluating human tumors, in Erlandson RA: Diagnostic Transmission Electron Microscopy of Tumors, With Clinicopathological, Immunohistochemical and Cytogenetic Correlations. New York, NY, Raven, 1994, p 28
32. Su I-J, Cheng AL, Kadin ME: Retinoic acid-induced differentiation and regression of cutaneous Ki-1 anaplastic large cell lymphoma: In vivo and in vitro observations. Lab Invest 70:144A, 1994 (abstr)
33. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS: Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer 68:362, 1991
34. + with a high content of reactive histiocytes). Histopathology 16:383, 1990
35. + T-cell lymphoma. Am J Surg Pathol 17:859, 1993
36. Chan J, Buchanan R, Fletcher CDM: Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol 14:383, 1990
37. Rosso R, Paulli M, Magrini U, Kindl S, Boveri E, Volpato G, Poggi S, Baglioni P, Pileri S: Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch B 416:229, 1989
38. Hsu S-M, Jaffe ES: Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol 82:29, 1984
39. Perkins PL, Ross CW, Schnitzer B: CD30-positive anaplastic large-cell lymphomas that express CD 15 but lack CD45: A possible diagnostic pitfall. Arch Pathol Lab Med 116:1192, 1992
40. Macon WR, Casey TT, Kinney MC, Collins RD, Cousar JB: Leu-22 (L60) - A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types. Am J Clin Pathol 95:696, 1991
41. Chittal SM, Caveriviere P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G: Monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Surg Pathol 12:9, 1988
42. Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145:1296, 1994
43. Wong KF, Chan JKC, Ng CS, Chu YC, Lam PWY, Yuen HL: Anaplastic large cell Ki-1 lymphoma involving bone marrow: Marrow findings and association with reactive hemophagocytosis. Am J Hematol 37:112, 1991
44. Agematsu K, Komiyama A: Ki-1 positive large cell anaplastic lymphoma: Multiple bone lytic lesions and interleukin-6. Leuk Lymph 7:309, 1992
45. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, Dorfman R: Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 68:1042, 1986
46. Krishnan J, Tomaszewski MM, Kao GF: Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J Cutan Pathol 20:193, 1993
47. De Bruin PC, Beljaards RC, van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JH, Kluin-Nelemans JC, Willemze R, Meijer CJ: Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell and null cell phenotype. Histopathology 23:127, 1993
48. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJLM, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer 71:2097, 1993
49. Offit K, Ladanyi M, Gangi MD, Ebrahim SAD, Filippa D, Chaganti RSK: Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
50. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakison E, Dopfer R, Bucsky P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
51. Chakravarti V, Kamani NR, Bayever E, Lange B, Herzog P, Sanders JE, August CS: Bone marrow transplantation for childhood Ki-1 lymphoma. J Clin Oncol 8:657, 1990
52. Körbling M, Przepiorka D, Van Besien K, Giralt S, Andersson B, Huh YO, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
53. Schmitz N, Linen DC, Dreger P, Goldstone AC, Boogaert MA, Goldstone AH, Ferrant A, Demuynck HMS, Link H, Zande A, Matcham J, Borkett KM, Schwab G: A randomized phase II study of Filgrastim-mobilized peripheral blood progenitor cell transplantation (PBPCT) in comparison with autologous bone marrow transplantation (ABMT) in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Blood 84:802, 1994 (suppl, abstr)